Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Benzodiazepines 1.4.3 Nonbenzodiazepines 1.4.4 Antidepressants 1.4.5 Orexin Antagonists 1.4.6 Melatonin Antagonists 1.4.7 Others 1.5 Market by Application 1.5.1 Global Insomnia Therapeutics Drugs Market Share by Application: 2020 VS 2026 1.5.2 Prescription 1.5.3 Over-the-Counter (OTC) 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Insomnia Therapeutics Drugs Market Perspective (2015-2026) 2.2 Insomnia Therapeutics Drugs Growth Trends by Regions 2.2.1 Insomnia Therapeutics Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Insomnia Therapeutics Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Insomnia Therapeutics Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Insomnia Therapeutics Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Insomnia Therapeutics Drugs Players by Market Size 3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2015-2020) 3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Insomnia Therapeutics Drugs Market Concentration Ratio 3.2.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2019 3.3 Insomnia Therapeutics Drugs Key Players Head office and Area Served 3.4 Key Players Insomnia Therapeutics Drugs Product Solution and Service 3.5 Date of Enter into Insomnia Therapeutics Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2015-2020) 4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2021-2026) 5 Insomnia Therapeutics Drugs Breakdown Data by Application (2015-2026) 5.1 Global Insomnia Therapeutics Drugs Market Size by Application (2015-2020) 5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Insomnia Therapeutics Drugs Market Size (2015-2020) 6.2 Insomnia Therapeutics Drugs Key Players in North America (2019-2020) 6.3 North America Insomnia Therapeutics Drugs Market Size by Type (2015-2020) 6.4 North America Insomnia Therapeutics Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Insomnia Therapeutics Drugs Market Size (2015-2020) 7.2 Insomnia Therapeutics Drugs Key Players in Europe (2019-2020) 7.3 Europe Insomnia Therapeutics Drugs Market Size by Type (2015-2020) 7.4 Europe Insomnia Therapeutics Drugs Market Size by Application (2015-2020) 8 China 8.1 China Insomnia Therapeutics Drugs Market Size (2015-2020) 8.2 Insomnia Therapeutics Drugs Key Players in China (2019-2020) 8.3 China Insomnia Therapeutics Drugs Market Size by Type (2015-2020) 8.4 China Insomnia Therapeutics Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Insomnia Therapeutics Drugs Market Size (2015-2020) 9.2 Insomnia Therapeutics Drugs Key Players in Japan (2019-2020) 9.3 Japan Insomnia Therapeutics Drugs Market Size by Type (2015-2020) 9.4 Japan Insomnia Therapeutics Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Insomnia Therapeutics Drugs Market Size (2015-2020) 10.2 Insomnia Therapeutics Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Insomnia Therapeutics Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Insomnia Therapeutics Drugs Market Size by Application (2015-2020) 11 India 11.1 India Insomnia Therapeutics Drugs Market Size (2015-2020) 11.2 Insomnia Therapeutics Drugs Key Players in India (2019-2020) 11.3 India Insomnia Therapeutics Drugs Market Size by Type (2015-2020) 11.4 India Insomnia Therapeutics Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Insomnia Therapeutics Drugs Market Size (2015-2020) 12.2 Insomnia Therapeutics Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Insomnia Therapeutics Drugs Market Size by Type (2015-2020) 12.4 Central & South America Insomnia Therapeutics Drugs Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Takeda Pharmaceutical Company Ltd. 13.1.1 Takeda Pharmaceutical Company Ltd. Company Details 13.1.2 Takeda Pharmaceutical Company Ltd. Business Overview and Its Total Revenue 13.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction 13.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2015-2020)) 13.1.5 Takeda Pharmaceutical Company Ltd. Recent Development 13.2 Vanda Pharmaceuticals 13.2.1 Vanda Pharmaceuticals Company Details 13.2.2 Vanda Pharmaceuticals Business Overview and Its Total Revenue 13.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction 13.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.2.5 Vanda Pharmaceuticals Recent Development 13.3 Merck & Co., Inc. 13.3.1 Merck & Co., Inc. Company Details 13.3.2 Merck & Co., Inc. Business Overview and Its Total Revenue 13.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction 13.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.3.5 Merck & Co., Inc. Recent Development 13.4 Pfizer Inc. 13.4.1 Pfizer Inc. Company Details 13.4.2 Pfizer Inc. Business Overview and Its Total Revenue 13.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction 13.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.4.5 Pfizer Inc. Recent Development 13.5 Teva Pharmaceutical Industries Ltd. 13.5.1 Teva Pharmaceutical Industries Ltd. Company Details 13.5.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue 13.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction 13.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.5.5 Teva Pharmaceutical Industries Ltd. Recent Development 13.6 Mylan N.V. 13.6.1 Mylan N.V. Company Details 13.6.2 Mylan N.V. Business Overview and Its Total Revenue 13.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction 13.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.6.5 Mylan N.V. Recent Development 13.7 Sumitomo Dainippon Pharma Co., Ltd 13.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details 13.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview and Its Total Revenue 13.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction 13.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development 13.8 Sanofi 13.8.1 Sanofi Company Details 13.8.2 Sanofi Business Overview and Its Total Revenue 13.8.3 Sanofi Insomnia Therapeutics Drugs Introduction 13.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.8.5 Sanofi Recent Development 13.9 Paratek Pharmaceuticals Inc. 13.9.1 Paratek Pharmaceuticals Inc. Company Details 13.9.2 Paratek Pharmaceuticals Inc. Business Overview and Its Total Revenue 13.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction 13.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.9.5 Paratek Pharmaceuticals Inc. Recent Development 13.10 Ebb Therapeutics 13.10.1 Ebb Therapeutics Company Details 13.10.2 Ebb Therapeutics Business Overview and Its Total Revenue 13.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction 13.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2015-2020) 13.10.5 Ebb Therapeutics Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Insomnia Therapeutics Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue Table 3. Ranking of Global Top Insomnia Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Benzodiazepines Table 6. Key Players of Nonbenzodiazepines Table 7. Key Players of Antidepressants Table 8. Key Players of Orexin Antagonists Table 9. Key Players of Melatonin Antagonists Table 10. Key Players of Others Table 11. Global Insomnia Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 12. Global Insomnia Therapeutics Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 13. Global Insomnia Therapeutics Drugs Market Size by Regions (2015-2020) (US$ Million) Table 14. Global Insomnia Therapeutics Drugs Market Share by Regions (2015-2020) Table 15. Global Insomnia Therapeutics Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 16. Global Insomnia Therapeutics Drugs Market Share by Regions (2021-2026) Table 17. Market Top Trends Table 18. Key Drivers: Impact Analysis Table 19. Key Challenges Table 20. Insomnia Therapeutics Drugs Market Growth Strategy Table 21. Main Points Interviewed from Key Insomnia Therapeutics Drugs Players Table 22. Global Insomnia Therapeutics Drugs Revenue by Players (2015-2020) (Million US$) Table 23. Global Insomnia Therapeutics Drugs Market Share by Players (2015-2020) Table 24. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapeutics Drugs as of 2019) Table 25. Global Insomnia Therapeutics Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 26. Key Players Headquarters and Area Served Table 27. Key Players Insomnia Therapeutics Drugs Product Solution and Service Table 28. Date of Enter into Insomnia Therapeutics Drugs Market Table 29. Mergers & Acquisitions, Expansion Plans Table 30. Global Insomnia Therapeutics Drugs Market Size by Type (2015-2020) (Million US$) Table 31. Global Insomnia Therapeutics Drugs Market Size Share by Type (2015-2020) Table 32. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2021-2026) Table 33. Global Insomnia Therapeutics Drugs Market Size Share by Application (2015-2020) Table 34. Global Insomnia Therapeutics Drugs Market Size by Application (2015-2020) (Million US$) Table 35. Global Insomnia Therapeutics Drugs Market Size Share by Application (2021-2026) Table 36. North America Key Players Insomnia Therapeutics Drugs Revenue (2019-2020) (Million US$) Table 37. North America Key Players Insomnia Therapeutics Drugs Market Share (2019-2020) Table 38. North America Insomnia Therapeutics Drugs Market Size by Type (2015-2020) (Million US$) Table 39. North America Insomnia Therapeutics Drugs Market Share by Type (2015-2020) Table 40. North America Insomnia Therapeutics Drugs Market Size by Application (2015-2020) (Million US$) Table 41. North America Insomnia Therapeutics Drugs Market Share by Application (2015-2020) Table 42. Europe Key Players Insomnia Therapeutics Drugs Revenue (2019-2020) (Million US$) Table 43. Europe Key Players Insomnia Therapeutics Drugs Market Share (2019-2020) Table 44. Europe Insomnia Therapeutics Drugs Market Size by Type (2015-2020) (Million US$) Table 45. Europe Insomnia Therapeutics Drugs Market Share by Type (2015-2020) Table 46. Europe Insomnia Therapeutics Drugs Market Size by Application (2015-2020) (Million US$) Table 47. Europe Insomnia Therapeutics Drugs Market Share by Application (2015-2020) Table 48. China Key Players Insomnia Therapeutics Drugs Revenue (2019-2020) (Million US$) Table 49. China Key Players Insomnia Therapeutics Drugs Market Share (2019-2020) Table 50. China Insomnia Therapeutics Drugs Market Size by Type (2015-2020) (Million US$) Table 51. China Insomnia Therapeutics Drugs Market Share by Type (2015-2020) Table 52. China Insomnia Therapeutics Drugs Market Size by Application (2015-2020) (Million US$) Table 53. China Insomnia Therapeutics Drugs Market Share by Application (2015-2020) Table 54. Japan Key Players Insomnia Therapeutics Drugs Revenue (2019-2020) (Million US$) Table 55. Japan Key Players Insomnia Therapeutics Drugs Market Share (2019-2020) Table 56. Japan Insomnia Therapeutics Drugs Market Size by Type (2015-2020) (Million US$) Table 57. Japan Insomnia Therapeutics Drugs Market Share by Type (2015-2020) Table 58. Japan Insomnia Therapeutics Drugs Market Size by Application (2015-2020) (Million US$) Table 59. Japan Insomnia Therapeutics Drugs Market Share by Application (2015-2020) Table 60. Southeast Asia Key Players Insomnia Therapeutics Drugs Revenue (2019-2020) (Million US$) Table 61. Southeast Asia Key Players Insomnia Therapeutics Drugs Market Share (2019-2020) Table 62. Southeast Asia Insomnia Therapeutics Drugs Market Size by Type (2015-2020) (Million US$) Table 63. Southeast Asia Insomnia Therapeutics Drugs Market Share by Type (2015-2020) Table 64. Southeast Asia Insomnia Therapeutics Drugs Market Size by Application (2015-2020) (Million US$) Table 65. Southeast Asia Insomnia Therapeutics Drugs Market Share by Application (2015-2020) Table 66. India Key Players Insomnia Therapeutics Drugs Revenue (2019-2020) (Million US$) Table 67. India Key Players Insomnia Therapeutics Drugs Market Share (2019-2020) Table 68. India Insomnia Therapeutics Drugs Market Size by Type (2015-2020) (Million US$) Table 69. India Insomnia Therapeutics Drugs Market Share by Type (2015-2020) Table 70. India Insomnia Therapeutics Drugs Market Size by Application (2015-2020) (Million US$) Table 71. India Insomnia Therapeutics Drugs Market Share by Application (2015-2020) Table 72. Central & South America Key Players Insomnia Therapeutics Drugs Revenue (2019-2020) (Million US$) Table 73. Central & South America Key Players Insomnia Therapeutics Drugs Market Share (2019-2020) Table 74. Central & South America Insomnia Therapeutics Drugs Market Size by Type (2015-2020) (Million US$) Table 75. Central & South America Insomnia Therapeutics Drugs Market Share by Type (2015-2020) Table 76. Central & South America Insomnia Therapeutics Drugs Market Size by Application (2015-2020) (Million US$) Table 77. Central & South America Insomnia Therapeutics Drugs Market Share by Application (2015-2020) Table 78. Takeda Pharmaceutical Company Ltd. Company Details Table 79. Takeda Pharmaceutical Company Ltd. Business Overview Table 80. Takeda Pharmaceutical Company Ltd. Product Table 81. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 82. Takeda Pharmaceutical Company Ltd. Recent Development Table 83. Vanda Pharmaceuticals Company Details Table 84. Vanda Pharmaceuticals Business Overview Table 85. Vanda Pharmaceuticals Product Table 86. Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 87. Vanda Pharmaceuticals Recent Development Table 88. Merck & Co., Inc. Company Details Table 89. Merck & Co., Inc. Business Overview Table 90. Merck & Co., Inc. Product Table 91. Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 92. Merck & Co., Inc. Recent Development Table 93. Pfizer Inc. Company Details Table 94. Pfizer Inc. Business Overview Table 95. Pfizer Inc. Product Table 96. Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 97. Pfizer Inc. Recent Development Table 98. Teva Pharmaceutical Industries Ltd. Company Details Table 99. Teva Pharmaceutical Industries Ltd. Business Overview Table 100. Teva Pharmaceutical Industries Ltd. Product Table 101. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 102. Teva Pharmaceutical Industries Ltd. Recent Development Table 103. Mylan N.V. Company Details Table 104. Mylan N.V. Business Overview Table 105. Mylan N.V. Product Table 106. Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 107. Mylan N.V. Recent Development Table 108. Sumitomo Dainippon Pharma Co., Ltd Company Details Table 109. Sumitomo Dainippon Pharma Co., Ltd Business Overview Table 110. Sumitomo Dainippon Pharma Co., Ltd Product Table 111. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 112. Sumitomo Dainippon Pharma Co., Ltd Recent Development Table 113. Sanofi Business Overview Table 114. Sanofi Product Table 115. Sanofi Company Details Table 116. Sanofi Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 117. Sanofi Recent Development Table 118. Paratek Pharmaceuticals Inc. Company Details Table 119. Paratek Pharmaceuticals Inc. Business Overview Table 120. Paratek Pharmaceuticals Inc. Product Table 121. Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 122. Paratek Pharmaceuticals Inc. Recent Development Table 123. Ebb Therapeutics Company Details Table 124. Ebb Therapeutics Business Overview Table 125. Ebb Therapeutics Product Table 126. Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2015-2020) (Million US$) Table 127. Ebb Therapeutics Recent Development Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Global Insomnia Therapeutics Drugs Market Share by Type: 2020 VS 2026 Figure 2. Benzodiazepines Features Figure 3. Nonbenzodiazepines Features Figure 4. Antidepressants Features Figure 5. Orexin Antagonists Features Figure 6. Melatonin Antagonists Features Figure 7. Others Features Figure 8. Global Insomnia Therapeutics Drugs Market Share by Application: 2020 VS 2026 Figure 9. Prescription Case Studies Figure 10. Over-the-Counter (OTC) Case Studies Figure 11. Insomnia Therapeutics Drugs Report Years Considered Figure 12. Global Insomnia Therapeutics Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Insomnia Therapeutics Drugs Market Share by Regions: 2020 VS 2026 Figure 14. Global Insomnia Therapeutics Drugs Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Insomnia Therapeutics Drugs Market Share by Players in 2019 Figure 17. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapeutics Drugs as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2019 Figure 19. North America Insomnia Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Insomnia Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Insomnia Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Insomnia Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Insomnia Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Insomnia Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Insomnia Therapeutics Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Takeda Pharmaceutical Company Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 28. Vanda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 30. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Merck & Co., Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 32. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Pfizer Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 34. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 36. Mylan N.V. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Mylan N.V. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 38. Sumitomo Dainippon Pharma Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Sanofi Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 42. Paratek Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Paratek Pharmaceuticals Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 44. Ebb Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2015-2020) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed

Takeda Pharmaceutical Company Ltd. Vanda Pharmaceuticals Merck & Co., Inc. Pfizer Inc. Teva Pharmaceutical Industries Ltd. Mylan N.V. Sumitomo Dainippon Pharma Co., Ltd Sanofi Paratek Pharmaceuticals Inc. Ebb Therapeutics